Sanofi (NYSE:SNY)‘s stock had its “underweight” rating reiterated by equities researchers at JPMorgan Chase & Co. in a note issued to investors on Thursday.

Several other analysts have also issued reports on the stock. Berenberg Bank raised shares of Sanofi from a “hold” rating to a “buy” rating in a research report on Thursday, September 8th. BNP Paribas raised shares of Sanofi from an “underperform” rating to a “neutral” rating in a research report on Tuesday, September 13th. TheStreet lowered shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Monday, August 22nd. Jefferies Group reissued a “hold” rating on shares of Sanofi in a research report on Wednesday, September 14th. Finally, Citigroup Inc. reissued a “neutral” rating on shares of Sanofi in a research report on Tuesday, June 28th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and four have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $60.50.

Shares of Sanofi (NYSE:SNY) opened at 38.43 on Thursday. The firm has a 50-day moving average of $40.00 and a 200-day moving average of $40.68. Sanofi has a 12 month low of $37.41 and a 12 month high of $51.88. The firm has a market cap of $98.92 billion, a price-to-earnings ratio of 21.21 and a beta of 1.01.

Institutional investors have recently modified their holdings of the company. Bessemer Group Inc. raised its position in shares of Sanofi by 77.1% in the second quarter. Bessemer Group Inc. now owns 3,445 shares of the company’s stock worth $144,000 after buying an additional 1,500 shares during the last quarter. Signaturefd LLC raised its position in shares of Sanofi by 16.4% in the second quarter. Signaturefd LLC now owns 3,480 shares of the company’s stock worth $146,000 after buying an additional 490 shares during the last quarter. JFS Wealth Advisors LLC raised its position in shares of Sanofi by 3.5% in the second quarter. JFS Wealth Advisors LLC now owns 3,961 shares of the company’s stock worth $166,000 after buying an additional 134 shares during the last quarter. BlackRock Institutional Trust Company N.A. bought a new position in shares of Sanofi during the first quarter worth approximately $175,000. Finally, Bradley Foster & Sargent Inc. CT bought a new position in shares of Sanofi during the second quarter worth approximately $205,000. 9.42% of the stock is currently owned by hedge funds and other institutional investors.

About Sanofi

Sanofi SA is a healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Company is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. The Company invests in emerging markets, diabetes solutions, vaccines, consumer health care, animal health, genzyme and other products.

5 Day Chart for NYSE:SNY

Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with Analyst Ratings Network's FREE daily email newsletter.